SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Terminix Global Holdings, Inc. (NYSE – TMX)
BALA CYNWYD – December 14, 2021 /Access Wire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Terminix Global Holdings, Inc. (“Terminix” or the “Company”) (NYSE – TMX) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to be acquired by Rentokil Initial plc. Under the terms of the Agreement, Rentokil Initial will issue to Terminix shareholders at closing aggregate consideration comprised of approximately 643.29 million new Rentokil Initial shares (representing approximately 128.66 million American depository shares (“ADSs”), implying a value of $55.00 per share of Terminix common stock, and represents an aggregate consideration mix of 80% stock and 20% cash.
The investigation concerns whether the Terminix Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Rentokil Initial is paying too little for the Company.
If you own shares of Terminix stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, or call toll free 855-576-4847.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.